- Home
- MVST vs GNFT Comparison
MVST vs GNFT Comparison
Compare MVST & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- GNFT
- Stock Information
- Founded
- MVST 2006
- GNFT 1999
- Country
- MVST United States
- GNFT France
- Employees
- MVST N/A
- GNFT N/A
- Industry
- MVST Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVST Miscellaneous
- GNFT Health Care
- Exchange
- MVST Nasdaq
- GNFT Nasdaq
- Market Cap
- MVST 1.3B
- GNFT 214.5M
- IPO Year
- MVST N/A
- GNFT 2019
- Fundamental
- Price
- MVST $3.61
- GNFT N/A
- Analyst Decision
- MVST Strong Buy
- GNFT Strong Buy
- Analyst Count
- MVST 1
- GNFT 1
- Target Price
- MVST $3.00
- GNFT $13.00
- AVG Volume (30 Days)
- MVST 9.2M
- GNFT 4.2K
- Earning Date
- MVST 08-07-2025
- GNFT 04-24-2025
- Dividend Yield
- MVST N/A
- GNFT N/A
- EPS Growth
- MVST N/A
- GNFT N/A
- EPS
- MVST N/A
- GNFT 0.03
- Revenue
- MVST $414,941,000.00
- GNFT $73,187,701.00
- Revenue This Year
- MVST $26.08
- GNFT $15.98
- Revenue Next Year
- MVST $29.71
- GNFT N/A
- P/E Ratio
- MVST N/A
- GNFT $125.14
- Revenue Growth
- MVST 21.68
- GNFT 105.01
- 52 Week Low
- MVST $0.15
- GNFT $2.55
- 52 Week High
- MVST $4.72
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- MVST 47.09
- GNFT 46.56
- Support Level
- MVST $3.42
- GNFT $3.61
- Resistance Level
- MVST $4.27
- GNFT $3.95
- Average True Range (ATR)
- MVST 0.32
- GNFT 0.14
- MACD
- MVST -0.12
- GNFT -0.01
- Stochastic Oscillator
- MVST 13.85
- GNFT 50.64
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.